Trial Profile
The Efficacy and Safety of CC-10004 in Chronic Cutaneous Sarcoidosis
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 14 Nov 2014
Price :
$35
*
At a glance
- Drugs Apremilast (Primary)
- Indications Sarcoidosis
- Focus Therapeutic Use
- 14 Nov 2014 New trial record